Search

everythinglearnresearchcommunity

for

Search:↓

New treatments are being explored to slow or reverse hereditary hair loss.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Obese and lean women with PCOS have different symptoms and need different treatments.

Exposure to certain chemicals in food and containers may increase the risk of early breast development in young girls.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.